← Leaderboards
Amy C. Anderson
University Of California San Francisco
$5,463,715
Attributed
$6,586,581
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$6,586,581 · 8
By mechanism
R01$6,117,895 · 4
P41$438,249 · 2
F32$24,437 · 1
R13$6,000 · 1
Top collaborators
- Dennis L Wright5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Clifford A Lowell$17,491,874
- Barbara I Kazmierczak$40,199,595
- Jeffrey Charles Lotz$49,562,566
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsDihydrofolate ReductaseBaseInhibitor/AntagonistResistanceStructureEnzymesDesignPathogenInfectionGenerationsPropertyTrimethoprimBinding (Molecular Function)LeadCellsAnti-Bacterial AgentsToxic EffectOrganismInhibitory Concentration 50Mammalian CellIn VitroDihydrofolate Reductase InhibitorAntibiotics
Grant awards (26)
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae$35,041
R01 · FY2016 · AI · contact PI
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae$547,689
R01 · FY2015 · AI · contact PI
Antimetabolites Effective against Resistant Gram-positive Bacteria$543,157
R01 · FY2015 · AI
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae$562,189
R01 · FY2014 · AI · contact PI
Antimetabolites Effective against Resistant Gram-positive Bacteria$557,657
R01 · FY2014 · AI
2014 Drug Resistance Gordon Research Conference$6,000
R13 · FY2014 · AI · contact PI
Targeting Bacillus DHFR: Structural Studies and Synthesis of Inhibitors$326,572
R01 · FY2012 · AI · contact PI
Targeting DHFR to Design Antimicrobial Agents$261,494
R01 · FY2012 · GM · contact PI
Targeting Bacillus DHFR: Structural Studies and Synthesis of Inhibitors$327,112
R01 · FY2011 · AI · contact PI
Targeting DHFR to Design Antimicrobial Agents$261,415
R01 · FY2011 · GM · contact PI
Targeting Bacillus DHFR: Structural Studies and Synthesis of Inhibitors$330,931
R01 · FY2010 · AI · contact PI
Targeting DHFR to Design Antimicrobial Agents$263,991
R01 · FY2010 · GM · contact PI
Targeting Bacillus DHFR: Structural Studies and Synthesis of Inhibitors$334,616
R01 · FY2009 · AI · contact PI
Targeting DHFR to Design Antimicrobial Agents$279,420
R01 · FY2009 · GM · contact PI
DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS$8,721
P41 · FY2009 · RR · contact PI
Targeting Bacillus DHFR: Structural Studies and Synthesis of Inhibitors$345,286
R01 · FY2008 · AI · contact PI
Design of Cryptosporidium parvum and Toxoplasma gondii DHFR-TS Inhibitors$216,110
R01 · FY2007 · GM · contact PI
Design of C. parvum and T. gondii DHFR-TS Inhibitors$210,373
R01 · FY2006 · GM · contact PI
Design of C. parvum and T. gondii DHFR-TS Inhibitors$151,841
R01 · FY2005 · GM
Design of C. parvum and T. gondii DHFR-TS Inhibitors$76,361
R01 · FY2005 · GM
Design of C. parvum and T. gondii DHFR-TS Inhibitors$243,320
R01 · FY2004 · GM
Design of C. parvum and T. gondii DHFR-TS Inhibitors$243,320
R01 · FY2003 · GM
CRYSTALLOGRAPHIC STUDIES OF RNA MOTIFS$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF RNA MOTIFS$143,176
P41 · FY2002 · RR
CRYSTALLOGRAPHIC STUDIES OF RNA MOTIFS$143,176
P41 · FY2001 · RR
DESIGN OF SELECTIVE INHIBITORS FOR THYMIDYLATE SYNTHASE$24,437
F32 · FY2000 · GM